pyruvaldehyde has been researched along with Kidney Failure, Chronic in 18 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "OX-LDL from chronic renal failure patients on both PD and HD stimulated greater adhesion than OX-LDL from the C subjects (68." | 2.70 | Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy. ( Collazo, R; Devaraj, S; Grundy, S; Islam, KN; Jialal, I; McDonald, L; O'Byrne, D, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 15 (83.33) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tezuka, Y | 1 |
| Nakaya, I | 1 |
| Nakayama, K | 3 |
| Nakayama, M | 3 |
| Yahata, M | 1 |
| Soma, J | 1 |
| Kabayama, S | 1 |
| Nakano, H | 1 |
| Zhu, WJ | 2 |
| Terawaki, H | 2 |
| Katoh, K | 1 |
| Satoh, T | 1 |
| Ito, S | 2 |
| Karg, E | 1 |
| Papp, F | 1 |
| Tassi, N | 1 |
| Janáky, T | 1 |
| Wittmann, G | 1 |
| Túri, S | 1 |
| Talukdar, D | 1 |
| Chaudhuri, BS | 1 |
| Ray, M | 1 |
| Ray, S | 1 |
| Inagi, R | 2 |
| Miyata, T | 2 |
| Ueda, Y | 2 |
| Yoshino, A | 2 |
| Nangaku, M | 1 |
| van Ypersele de Strihou, C | 2 |
| Kurokawa, K | 2 |
| Zeier, M | 1 |
| Schwenger, V | 1 |
| Deppisch, R | 1 |
| Haug, U | 1 |
| Weigel, K | 1 |
| Bahner, U | 1 |
| Wanner, C | 1 |
| Schneider, H | 1 |
| Henle, T | 1 |
| Ritz, E | 1 |
| Uribarri, J | 1 |
| Peppa, M | 1 |
| Cai, W | 1 |
| Goldberg, T | 1 |
| Lu, M | 1 |
| Baliga, S | 1 |
| Vassalotti, JA | 1 |
| Vlassara, H | 1 |
| Ward, RA | 1 |
| McLeish, KR | 1 |
| Lapolla, A | 2 |
| Reitano, R | 2 |
| Seraglia, R | 2 |
| Sartore, G | 1 |
| Ragazzi, E | 2 |
| Traldi, P | 2 |
| Flamini, R | 1 |
| Lupo, A | 1 |
| Aricò, NC | 1 |
| Rugiu, C | 1 |
| Tubaro, M | 1 |
| Rabbani, N | 1 |
| Sebekova, K | 2 |
| Heidland, A | 1 |
| Thornalley, PJ | 1 |
| Shirota, Y | 1 |
| Sato, T | 1 |
| Kohno, M | 1 |
| Odani, H | 2 |
| Shinzato, T | 2 |
| Usami, J | 2 |
| Matsumoto, Y | 2 |
| Brinkmann Frye, E | 1 |
| Baynes, JW | 1 |
| Maeda, K | 2 |
| Takeuchi, M | 1 |
| Makita, Z | 1 |
| Bucala, R | 1 |
| Suzuki, T | 1 |
| Koike, T | 1 |
| Kameda, Y | 1 |
| Goffin, E | 1 |
| Ishibashi, Y | 1 |
| Izuhara, Y | 1 |
| Saito, A | 1 |
| O'Byrne, D | 1 |
| Devaraj, S | 1 |
| Islam, KN | 1 |
| Collazo, R | 1 |
| McDonald, L | 1 |
| Grundy, S | 1 |
| Jialal, I | 1 |
| Nohara, Y | 1 |
| Usui, T | 1 |
| Kinoshita, T | 1 |
| Watanabe, M | 1 |
4 trials available for pyruvaldehyde and Kidney Failure, Chronic
| Article | Year |
|---|---|
Biological effects of electrolyzed water in hemodialysis.
Topics: Adult; Aged; Cytochromes c; Electrodes; Electrolysis; Feasibility Studies; Female; Hemodialysis Solu | 2009 |
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?
Topics: Adult; Ascitic Fluid; CA-125 Antigen; Cross-Over Studies; Deoxyglucose; Female; Fluorescence; Glucos | 2003 |
Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Topics: Aged; Amino Acids; Arginine; Deoxyglucose; Dialysis Solutions; Female; Filtration; Glucans; Glucose; | 2000 |
Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
Topics: Adult; Arteriosclerosis; Autoantibodies; Case-Control Studies; Cell Adhesion; Cell Adhesion Molecule | 2001 |
14 other studies available for pyruvaldehyde and Kidney Failure, Chronic
| Article | Year |
|---|---|
Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetic Nephropathies; Disease P | 2019 |
Enhanced methylglyoxal formation in the erythrocytes of hemodialyzed patients.
Topics: Adult; Case-Control Studies; Erythrocytes; Female; Glutathione; Humans; Kidney Failure, Chronic; Lac | 2009 |
Critical evaluation of toxic versus beneficial effects of methylglyoxal.
Topics: Animals; Arginine; Cataract; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Delive | 2009 |
Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid.
Topics: Animals; CHO Cells; Cricetinae; Deoxyglucose; Dialysis Solutions; Gene Expression Regulation, Enzymo | 2002 |
Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.
Topics: Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Diet; Diet Records; Food Analysi | 2003 |
Methylglyoxal: a stimulus to neutrophil oxygen radical production in chronic renal failure?
Topics: Exocytosis; Humans; Kidney Failure, Chronic; Neutrophils; p38 Mitogen-Activated Protein Kinases; Pyr | 2004 |
Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.
Topics: Aged; Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Dialysis Solutions; Glycated Hemoglobin; G | 2005 |
Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis.
Topics: Aged; Blood Proteins; Female; Glyoxal; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritonea | 2005 |
Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function.
Topics: Animals; Body Weight; Disease Models, Animal; Glycation End Products, Advanced; Glyoxal; Kidney Fail | 2007 |
Polymorphonuclear leukocyte injury by methylglyoxal and hydrogen peroxide: a possible pathological role for enhanced oxidative stress in chronic kidney disease.
Topics: Apoptosis; Cell Survival; Drug Synergism; Free Radicals; Humans; Hydrogen Peroxide; In Vitro Techniq | 2008 |
Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia.
Topics: Cross-Linking Reagents; Female; Glyoxal; Humans; Imidazoles; Kidney Failure, Chronic; Lysine; Male; | 1998 |
Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction.
Topics: 2-Naphthylamine; Aging; Arginine; Chromatography, Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; G | 1999 |
Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Topics: Animals; Antibodies; Cattle; Chromatography, Affinity; Cross Reactions; Diabetes Mellitus, Type 2; E | 2000 |
Generation of superoxide anions during the reaction of guanidino compounds with methylglyoxal.
Topics: Guanidine; Guanidines; Humans; Kidney Failure, Chronic; Oxidative Stress; Pyruvaldehyde; Superoxides | 2002 |